Marina Tusup
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanoma.
Journal: Nature medicine
Published: August 01, 2025
Intralymphatic Administration of Naked mRNA Induces Allergen-Specific IgG, Promotes Th1 Responses and Reduces Anaphylactic Potential.
Journal: Allergy
Published: December 05, 2024
Feasibility of multiomics tumor profiling for guiding treatment of melanoma.
Journal: Nature medicine
Published: July 09, 2024
RNA with chemotherapeutic base analogues as a dual-functional anti-cancer drug.
Journal: Oncoimmunology
Published: November 24, 2022
Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-Coding RNA 2021, 7, 5.
Journal: Non-coding RNA
Published: November 10, 2022
The A to I editing landscape in melanoma and its relation to clinical outcome.
Journal: RNA biology
Published: August 22, 2022
Epitranscriptomics modifier pentostatin indirectly triggers Toll-like receptor 3 and can enhance immune infiltration in tumors.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 14, 2021
mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma.
Journal: Pharmaceutics
Published: May 07, 2021
Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma.
Journal: Non-coding RNA
Published: September 18, 2020
Design of in vitro Transcribed mRNA Vectors for Research and Therapy.
Journal: Chimia
Published: May 24, 2019
Charting DENR-dependent translation reinitiation uncovers predictive uORF features and links to circadian timekeeping via Clock.
Journal: Nucleic acids research
Published: August 28, 2018
Epitranscriptomics of cancer.
Journal: World journal of clinical oncology
Published: February 07, 2018
Last Updated: 09/26/2026